Global and China Antibody Drug Conjugate (ADC) Drug Market Size, Status and Forecast 2020-2026

September 2020 | 125 pages | ID: G60C3376BAE4EN
QYResearch

Abstracts

Global Antibody Drug Conjugate (ADC) Drug Scope and Market Size
Antibody Drug Conjugate (ADC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drug Conjugate (ADC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• by Technology
• Mmunomedics Technology
• Immunogen Technology
• Seattle Genetics Technology
• Others
• by Product Type
• Kadcyla
• Adcertis

Market segment by Application, split into

• Biotechnology Companies
• Specialized Cancer Centers
• Biopharmaceutical Companies
• Academic Research Institutes
• Hospitals
• Others

Based on regional and country-level analysis, the Antibody Drug Conjugate (ADC) Drug market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Antibody Drug Conjugate (ADC) Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Oxford Bio Therapeutics
• Synthon
• Progenics Pharmaceuticals
• Bayer HealthCare
• Millennium Pharmaceuticals
• Pfizer
• Concortis Bio therapeutics
• Roche Holding AG
• Seattle Genetics
• Heidelberg Pharma
• Mersana Therapeutics
• Astellas Pharma/Agensys
• AbbVie Inc
• Celldex Therapeutics
• Immunomedics
• Agensys
• Genentech
• ImmunoGen
• Sanofi
• Genmab
• Amgen
• Novartis
• Eli Lilly

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Mmunomedics Technology
  1.2.3 Immunogen Technology
  1.2.4 Seattle Genetics Technology
  1.2.5 Others
1.3 Market by Application
  1.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2020 VS 2026
  1.3.2 Biotechnology Companies
  1.3.3 Specialized Cancer Centers
  1.3.4 Biopharmaceutical Companies
  1.3.5 Academic Research Institutes
  1.3.6 Hospitals
  1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Antibody Drug Conjugate (ADC) Drug Market Perspective (2015-2026)
2.2 Global Antibody Drug Conjugate (ADC) Drug Growth Trends by Regions
  2.2.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antibody Drug Conjugate (ADC) Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Market Size
  3.1.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue (2015-2020)
  3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2015-2020)
3.2 Global Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antibody Drug Conjugate (ADC) Drug Revenue
3.4 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio
  3.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate (ADC) Drug Revenue in 2019
3.5 Key Players Antibody Drug Conjugate (ADC) Drug Area Served
3.6 Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
3.7 Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ANTIBODY DRUG CONJUGATE (ADC) DRUG BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Type (2015-2020)
4.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2021-2026)

5 ANTIBODY DRUG CONJUGATE (ADC) DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Application (2015-2020)
5.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
6.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
6.4 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
7.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
8.2 China Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
8.3 China Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
8.4 China Antibody Drug Conjugate (ADC) Drug Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
9.2 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
9.3 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
9.4 Japan Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size (2015-2026)
10.2 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020)
10.3 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020)
10.4 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11 KEY PLAYERS PROFILES

11.1 Oxford Bio Therapeutics
  11.1.1 Oxford Bio Therapeutics Company Details
  11.1.2 Oxford Bio Therapeutics Business Overview
  11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
  11.1.4 Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020))
  11.1.5 Oxford Bio Therapeutics Recent Development
11.2 Synthon
  11.2.1 Synthon Company Details
  11.2.2 Synthon Business Overview
  11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Introduction
  11.2.4 Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.2.5 Synthon Recent Development
11.3 Progenics Pharmaceuticals
  11.3.1 Progenics Pharmaceuticals Company Details
  11.3.2 Progenics Pharmaceuticals Business Overview
  11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
  11.3.4 Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.3.5 Progenics Pharmaceuticals Recent Development
11.4 Bayer HealthCare
  11.4.1 Bayer HealthCare Company Details
  11.4.2 Bayer HealthCare Business Overview
  11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Introduction
  11.4.4 Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.4.5 Bayer HealthCare Recent Development
11.5 Millennium Pharmaceuticals
  11.5.1 Millennium Pharmaceuticals Company Details
  11.5.2 Millennium Pharmaceuticals Business Overview
  11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
  11.5.4 Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Pfizer
  11.6.1 Pfizer Company Details
  11.6.2 Pfizer Business Overview
  11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Introduction
  11.6.4 Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.6.5 Pfizer Recent Development
11.7 Concortis Bio therapeutics
  11.7.1 Concortis Bio therapeutics Company Details
  11.7.2 Concortis Bio therapeutics Business Overview
  11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
  11.7.4 Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.7.5 Concortis Bio therapeutics Recent Development
11.8 Roche Holding AG
  11.8.1 Roche Holding AG Company Details
  11.8.2 Roche Holding AG Business Overview
  11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Introduction
  11.8.4 Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.8.5 Roche Holding AG Recent Development
11.9 Seattle Genetics
  11.9.1 Seattle Genetics Company Details
  11.9.2 Seattle Genetics Business Overview
  11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Introduction
  11.9.4 Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.9.5 Seattle Genetics Recent Development
11.10 Heidelberg Pharma
  11.10.1 Heidelberg Pharma Company Details
  11.10.2 Heidelberg Pharma Business Overview
  11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Introduction
  11.10.4 Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  11.10.5 Heidelberg Pharma Recent Development
11.11 Mersana Therapeutics
  10.11.1 Mersana Therapeutics Company Details
  10.11.2 Mersana Therapeutics Business Overview
  10.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
  10.11.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.11.5 Mersana Therapeutics Recent Development
11.12 Astellas Pharma/Agensys
  10.12.1 Astellas Pharma/Agensys Company Details
  10.12.2 Astellas Pharma/Agensys Business Overview
  10.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Introduction
  10.12.4 Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.12.5 Astellas Pharma/Agensys Recent Development
11.13 AbbVie Inc
  10.13.1 AbbVie Inc Company Details
  10.13.2 AbbVie Inc Business Overview
  10.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Introduction
  10.13.4 AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.13.5 AbbVie Inc Recent Development
11.14 Celldex Therapeutics
  10.14.1 Celldex Therapeutics Company Details
  10.14.2 Celldex Therapeutics Business Overview
  10.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
  10.14.4 Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.14.5 Celldex Therapeutics Recent Development
11.15 Immunomedics
  10.15.1 Immunomedics Company Details
  10.15.2 Immunomedics Business Overview
  10.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Introduction
  10.15.4 Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.15.5 Immunomedics Recent Development
11.16 Agensys
  10.16.1 Agensys Company Details
  10.16.2 Agensys Business Overview
  10.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Introduction
  10.16.4 Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.16.5 Agensys Recent Development
11.17 Genentech
  10.17.1 Genentech Company Details
  10.17.2 Genentech Business Overview
  10.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Introduction
  10.17.4 Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.17.5 Genentech Recent Development
11.18 ImmunoGen
  10.18.1 ImmunoGen Company Details
  10.18.2 ImmunoGen Business Overview
  10.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Introduction
  10.18.4 ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.18.5 ImmunoGen Recent Development
11.19 Sanofi
  10.19.1 Sanofi Company Details
  10.19.2 Sanofi Business Overview
  10.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Introduction
  10.19.4 Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.19.5 Sanofi Recent Development
11.20 Genmab
  10.20.1 Genmab Company Details
  10.20.2 Genmab Business Overview
  10.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Introduction
  10.20.4 Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.20.5 Genmab Recent Development
11.21 Amgen
  10.21.1 Amgen Company Details
  10.21.2 Amgen Business Overview
  10.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Introduction
  10.21.4 Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.21.5 Amgen Recent Development
11.22 Novartis
  10.22.1 Novartis Company Details
  10.22.2 Novartis Business Overview
  10.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Introduction
  10.22.4 Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.22.5 Novartis Recent Development
11.23 Eli Lilly
  10.23.1 Eli Lilly Company Details
  10.23.2 Eli Lilly Business Overview
  10.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Introduction
  10.23.4 Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
  10.23.5 Eli Lilly Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Mmunomedics Technology
Table 4. Key Players of Immunogen Technology
Table 5. Key Players of Seattle Genetics Technology
Table 6. Key Players of Others
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Market Share by Regions (2015-2020)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Antibody Drug Conjugate (ADC) Drug Market Share by Regions (2021-2026)
Table 13. Antibody Drug Conjugate (ADC) Drug Market Market Trends
Table 14. Antibody Drug Conjugate (ADC) Drug Market Drivers
Table 15. Antibody Drug Conjugate (ADC) Drug Market Challenges
Table 16. Antibody Drug Conjugate (ADC) Drug Market Restraints
Table 17. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Antibody Drug Conjugate (ADC) Drug Market Share by Players (2015-2020)
Table 19. Global Top Antibody Drug Conjugate (ADC) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2019)
Table 20. Global Antibody Drug Conjugate (ADC) Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Antibody Drug Conjugate (ADC) Drug Market Size Share by Type (2015-2020)
Table 26. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2021-2026)
Table 27. Global Antibody Drug Conjugate (ADC) Drug Market Size Share by Application (2015-2020)
Table 28. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Antibody Drug Conjugate (ADC) Drug Market Size Share by Application (2021-2026)
Table 30. North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Antibody Drug Conjugate (ADC) Drug Market Share by Type (2015-2020)
Table 32. North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Antibody Drug Conjugate (ADC) Drug Market Share by Application (2015-2020)
Table 34. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Antibody Drug Conjugate (ADC) Drug Market Share by Country (2015-2020)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Antibody Drug Conjugate (ADC) Drug Market Share by Type (2015-2020)
Table 38. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Antibody Drug Conjugate (ADC) Drug Market Share by Application (2015-2020)
Table 40. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Antibody Drug Conjugate (ADC) Drug Market Share by Country (2015-2020)
Table 42. China Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 43. China Antibody Drug Conjugate (ADC) Drug Market Share by Type (2015-2020)
Table 44. China Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 45. China Antibody Drug Conjugate (ADC) Drug Market Share by Application (2015-2020)
Table 46. China Antibody Drug Conjugate (ADC) Drug Market Size by Region (US$ Million) (2015-2020)
Table 47. China Antibody Drug Conjugate (ADC) Drug Market Share by Region (2015-2020)
Table 48. Japan Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Antibody Drug Conjugate (ADC) Drug Market Share by Type (2015-2020)
Table 50. Japan Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Antibody Drug Conjugate (ADC) Drug Market Share by Application (2015-2020)
Table 52. Japan Antibody Drug Conjugate (ADC) Drug Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Antibody Drug Conjugate (ADC) Drug Market Share by Country (2015-2020)
Table 54. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Share by Type (2015-2020)
Table 56. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Share by Application (2015-2020)
Table 58. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Share by Country (2015-2020)
Table 60. Oxford Bio Therapeutics Company Details
Table 61. Oxford Bio Therapeutics Business Overview
Table 62. Oxford Bio Therapeutics Product
Table 63. Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 64. Oxford Bio Therapeutics Recent Development
Table 65. Synthon Company Details
Table 66. Synthon Business Overview
Table 67. Synthon Product
Table 68. Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 69. Synthon Recent Development
Table 70. Progenics Pharmaceuticals Company Details
Table 71. Progenics Pharmaceuticals Business Overview
Table 72. Progenics Pharmaceuticals Product
Table 73. Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 74. Progenics Pharmaceuticals Recent Development
Table 75. Bayer HealthCare Company Details
Table 76. Bayer HealthCare Business Overview
Table 77. Bayer HealthCare Product
Table 78. Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 79. Bayer HealthCare Recent Development
Table 80. Millennium Pharmaceuticals Company Details
Table 81. Millennium Pharmaceuticals Business Overview
Table 82. Millennium Pharmaceuticals Product
Table 83. Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 84. Millennium Pharmaceuticals Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Concortis Bio therapeutics Company Details
Table 91. Concortis Bio therapeutics Business Overview
Table 92. Concortis Bio therapeutics Product
Table 93. Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 94. Concortis Bio therapeutics Recent Development
Table 95. Roche Holding AG Business Overview
Table 96. Roche Holding AG Product
Table 97. Roche Holding AG Company Details
Table 98. Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 99. Roche Holding AG Recent Development
Table 100. Seattle Genetics Company Details
Table 101. Seattle Genetics Business Overview
Table 102. Seattle Genetics Product
Table 103. Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 104. Seattle Genetics Recent Development
Table 105. Heidelberg Pharma Company Details
Table 106. Heidelberg Pharma Business Overview
Table 107. Heidelberg Pharma Product
Table 108. Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 109. Heidelberg Pharma Recent Development
Table 110. Mersana Therapeutics Company Details
Table 111. Mersana Therapeutics Business Overview
Table 112. Mersana Therapeutics Product
Table 113. Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 114. Mersana Therapeutics Recent Development
Table 115. Astellas Pharma/Agensys Company Details
Table 116. Astellas Pharma/Agensys Business Overview
Table 117. Astellas Pharma/Agensys Product
Table 118. Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 119. Astellas Pharma/Agensys Recent Development
Table 120. AbbVie Inc Company Details
Table 121. AbbVie Inc Business Overview
Table 122. AbbVie Inc Product
Table 123. AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 124. AbbVie Inc Recent Development
Table 125. Celldex Therapeutics Company Details
Table 126. Celldex Therapeutics Business Overview
Table 127. Celldex Therapeutics Product
Table 128. Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 129. Celldex Therapeutics Recent Development
Table 130. Immunomedics Company Details
Table 131. Immunomedics Business Overview
Table 132. Immunomedics Product
Table 133. Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 134. Immunomedics Recent Development
Table 135. Agensys Company Details
Table 136. Agensys Business Overview
Table 137. Agensys Product
Table 138. Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 139. Agensys Recent Development
Table 140. Genentech Company Details
Table 141. Genentech Business Overview
Table 142. Genentech Product
Table 143. Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 144. Genentech Recent Development
Table 145. ImmunoGen Company Details
Table 146. ImmunoGen Business Overview
Table 147. ImmunoGen Product
Table 148. ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 149. ImmunoGen Recent Development
Table 150. Sanofi Company Details
Table 151. Sanofi Business Overview
Table 152. Sanofi Product
Table 153. Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 154. Sanofi Recent Development
Table 155. Genmab Company Details
Table 156. Genmab Business Overview
Table 157. Genmab Product
Table 158. Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 159. Genmab Recent Development
Table 160. Amgen Company Details
Table 161. Amgen Business Overview
Table 162. Amgen Product
Table 163. Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 164. Amgen Recent Development
Table 165. Novartis Company Details
Table 166. Novartis Business Overview
Table 167. Novartis Product
Table 168. Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 169. Novartis Recent Development
Table 170. Eli Lilly Company Details
Table 171. Eli Lilly Business Overview
Table 172. Eli Lilly Product
Table 173. Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2015-2020) (US$ Million)
Table 174. Eli Lilly Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antibody Drug Conjugate (ADC) Drug Market Share by Type: 2020 VS 2026
Figure 2. Mmunomedics Technology Features
Figure 3. Immunogen Technology Features
Figure 4. Seattle Genetics Technology Features
Figure 5. Others Features
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology Companies Case Studies
Figure 8. Specialized Cancer Centers Case Studies
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Academic Research Institutes Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Market Size (US$ Million), YoY Growth 2015-2026
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market Share by Regions: 2020 VS 2026
Figure 16. Global Antibody Drug Conjugate (ADC) Drug Market Share by Regions (2021-2026)
Figure 17. Global Antibody Drug Conjugate (ADC) Drug Market Share by Players in 2019
Figure 18. Global Top Antibody Drug Conjugate (ADC) Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue in 2019
Figure 20. North America Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. United States Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Europe Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Germany Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. France Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. U.K. Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Italy Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Russia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Nordic Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Rest of Europe Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. China Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Japan Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. South Korea Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. India Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Australia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Latin America Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Rest of Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Oxford Bio Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 48. Synthon Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 49. Progenics Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 50. Bayer HealthCare Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 51. Millennium Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 52. Pfizer Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 53. Concortis Bio therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 54. Roche Holding AG Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 55. Seattle Genetics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 56. Heidelberg Pharma Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 57. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 58. Astellas Pharma/Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 59. AbbVie Inc Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 60. Celldex Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 61. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 62. Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 63. Genentech Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 64. ImmunoGen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 65. Sanofi Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 66. Genmab Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 67. Amgen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 68. Novartis Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 69. Eli Lilly Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2015-2020)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed